المؤلفون: Haidar G; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Hodges JC; Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Bilderback A; Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Lukanski A; Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Linstrum K; Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Postol B; Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Troyan R; Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Wisniewski MK; Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Coughenour L; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Heaps A; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Jacobs JL; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Hughes Kramer K; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Klamar-Blain C; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Kohl J; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Liang W; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Morris B; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Macatangay BJC; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Parikh UM; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Sobolewksi MD; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Musgrove C; Internal Medicine Residency Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Crandall MD; Clinical Laboratory, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Mahon J; Clinical Laboratory, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Mulvey K; Clinical Laboratory, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Collins K; Clinical Analytics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., King AC; Clinical Analytics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Wells A; Clinical Laboratory, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Zapf R; Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Agha M; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Minnier T; Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Angus DC; Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Mellors JW; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

المصدر: The Journal of infectious diseases [J Infect Dis] 2024 May 15; Vol. 229 (5), pp. 1328-1340.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Immunocompromised Host* , COVID-19*/immunology , COVID-19*/prevention & control , Antibodies, Viral*/blood , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , SARS-CoV-2*/immunology , Immunity, Cellular* , Immunity, Humoral*, Humans ; Male ; Female ; Prospective Studies ; Middle Aged ; Adult ; Health Personnel ; mRNA Vaccines ; T-Lymphocytes/immunology ; Aged ; Immunoglobulin G/blood ; Interferon-gamma

المؤلفون: Garza-Silva A; Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, Mexico., Rivera-Salinas D; Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, Mexico., Rivera-Cavazos A; Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, Mexico., Fernández-Chau IF; Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, Mexico.; Vicerrectoría de Ciencias de la Salud, Escuela de Medicina, Universidad de Monterrey, San Pedro Garza García, Mexico., Cepeda-Medina AB; Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, Mexico.; Vicerrectoría de Ciencias de la Salud, Escuela de Medicina, Universidad de Monterrey, San Pedro Garza García, Mexico., Morales-Rodríguez DP; Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, Mexico.; Vicerrectoría de Ciencias de la Salud, Escuela de Medicina, Universidad de Monterrey, San Pedro Garza García, Mexico., Barco-Flores IA; Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, Mexico., Sanz-Sánchez MÁ; Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, Mexico.; Vicerrectoría de Ciencias de la Salud, Escuela de Medicina, Universidad de Monterrey, San Pedro Garza García, Mexico., Acciardi C; Health Secretary, Unidad Hospitalaria San José, Campana, Argentina., Paez-Bo G; Laboratory Department, Hospital Interzonal General de Agudos San Felipe, San Nicolás de los Arroyos, Argentina., Teixeira MM; Biochemistry and Immunology Department, Instituto Ciencias Biologicas (ICB), Universidad Federal de Minas Gerais, Belo Horizonte, Brazil., Azzolini E; Instituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Pozzi C; Instituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Milan, Italy., Rescigno M; Instituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Romero-Ibarguengoitia ME; Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, Mexico.; Vicerrectoría de Ciencias de la Salud, Escuela de Medicina, Universidad de Monterrey, San Pedro Garza García, Mexico.

المصدر: Frontiers in immunology [Front Immunol] 2024 May 14; Vol. 15, pp. 1403784. Date of Electronic Publication: 2024 May 14 (Print Publication: 2024).

نوع المنشور: Journal Article; Observational Study; Multicenter Study

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/prevention & control , COVID-19*/immunology , SARS-CoV-2*/immunology , Immunization, Secondary* , Antibodies, Viral*/blood , Antibodies, Viral*/immunology , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , BNT162 Vaccine*/immunology , BNT162 Vaccine*/administration & dosage, Humans ; Argentina ; Male ; Female ; Middle Aged ; Mexico ; Adult ; Follow-Up Studies ; Aged ; Longitudinal Studies ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Vaccine Efficacy ; ChAdOx1 nCoV-19/immunology ; Vaccines, Synthetic

المؤلفون: Soliman R; Department of Microbiology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt., Yousef M; Department of Veterinary Hygiene, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt., Gelil SA; Department of Microbiology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt., Aboul-Ella H; Department of Microbiology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt. hasanabo@cu.edu.eg.

المصدر: BMC veterinary research [BMC Vet Res] 2024 May 03; Vol. 20 (1), pp. 173. Date of Electronic Publication: 2024 May 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101249759 Publication Model: Electronic Cited Medium: Internet ISSN: 1746-6148 (Electronic) Linking ISSN: 17466148 NLM ISO Abbreviation: BMC Vet Res Subsets: MEDLINE

مواضيع طبية MeSH: Streptococcus equi*/immunology , Mice, Inbred BALB C* , Streptococcal Infections*/veterinary , Streptococcal Infections*/prevention & control , Streptococcal Infections*/microbiology , Streptococcal Infections*/immunology , Horse Diseases*/prevention & control , Horse Diseases*/microbiology , Horse Diseases*/immunology , Streptococcal Vaccines*/immunology , Streptococcal Vaccines*/administration & dosage , Streptococcus*, Animals ; Horses ; Rabbits ; Mice ; Female ; Antibodies, Bacterial/blood ; Adjuvants, Immunologic/administration & dosage ; Vaccines, Inactivated/immunology

SCR Organism: Streptococcus equi subsp. equi

المؤلفون: Forcada-Segarra JA; Asociación Nacional de Enfermería y Vacunas (ANENVAC), Valencia, Spain; Public Health Nurse, Valencia, Spain., Cuesta-Esteve I; Asociación Nacional de Enfermería y Vacunas (ANENVAC), Valencia, Spain; Nurse and Matron, Zaragoza, Spain., García Pérez A; Asociación Nacional de Enfermería y Vacunas (ANENVAC), Valencia, Spain; Primary Care Nurse, Cáceres, Spain., Sancho Martínez R; Asociación Nacional de Enfermería y Vacunas (ANENVAC), Valencia, Spain; Vaccinology, Public Health, Basque Government, San Sebastian, Spain., Rey Biel P; ESADE Business School, Universitat Ramón Llull, Spain., Carrera-Barnet G; Market Access, Sanofi, Barcelona, Spain., Cuadra-Grande A; Pharmacoeconomics and Outcomes Research Iberia (PORIB), Paseo Joaquín Rodrigo 4 e Letter I, Pozuelo de Alarcón, 28224, Madrid, Spain. Electronic address: adelacuadra@porib.com., Casado MÁ; Pharmacoeconomics and Outcomes Research Iberia (PORIB), Paseo Joaquín Rodrigo 4 e Letter I, Pozuelo de Alarcón, 28224, Madrid, Spain., Drago G; Medical Advisor Vaccines, Sanofi, Barcelona, Spain., Gómez-Barrera M; Pharmacoeconomics and Outcomes Research Iberia (PORIB), Paseo Joaquín Rodrigo 4 e Letter I, Pozuelo de Alarcón, 28224, Madrid, Spain., López-Belmonte JL; Market Access, Sanofi, Madrid, Spain.

المصدر: Public health [Public Health] 2024 May; Vol. 230, pp. 163-171. Date of Electronic Publication: 2024 Mar 30.

نوع المنشور: Review; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376507 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5616 (Electronic) Linking ISSN: 00333506 NLM ISO Abbreviation: Public Health Subsets: MEDLINE

مواضيع طبية MeSH: Neisseria meningitidis* , Meningococcal Vaccines* , Nurses*, Humans ; Spain ; Vaccines, Conjugate ; Choice Behavior ; Pharmaceutical Preparations

المؤلفون: Laverdure S; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory, Frederick, MD. Electronic address: sylvain.laverdure@nih.gov., Kazadi D; Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of Congo., Kone K; University Clinical Research Center (UCRC), University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali., Callier V; Clinical Monitoring Research Program Directorate, Frederick National Laboratory, Frederick, MD., Dabitao D; University Clinical Research Center (UCRC), University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali., Dennis D; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia., Haidara MC; Partnership of Clinical Research in Guinea (PREGUI), Centre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maferinyah, Guinea., Hunsberger S; National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Mbaya OT; Clinical Monitoring Research Program Directorate, Frederick National Laboratory, Frederick, MD., Ridzon R; National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Sereti I; National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Shaw-Saliba K; National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

مؤلفون مشاركون: InVITE Study Team

المصدر: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 May; Vol. 142, pp. 106985. Date of Electronic Publication: 2024 Feb 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511 (Electronic) Linking ISSN: 12019712 NLM ISO Abbreviation: Int J Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/diagnosis , COVID-19*/epidemiology , COVID-19*/prevention & control , Vaccines*, Adult ; Humans ; SARS-CoV-2 ; COVID-19 Vaccines ; Guinea/epidemiology ; Liberia/epidemiology ; Mali ; Democratic Republic of the Congo/epidemiology ; Seroepidemiologic Studies ; Antibodies, Viral

المؤلفون: Saraf A; Gennova Biopharmaceuticals Limited, Pune, India., Gurjar R; Gennova Biopharmaceuticals Limited, Pune, India., Kaviraj S; Gennova Biopharmaceuticals Limited, Pune, India., Kulkarni A; Gennova Biopharmaceuticals Limited, Pune, India., Kumar D; Gennova Biopharmaceuticals Limited, Pune, India., Kulkarni R; Department of Communicable Diseases, Interactive Research School for Health Affairs, Bharati Vidyapeeth (Deemed to Be University), Pune, India., Virkar R; Department of Communicable Diseases, Interactive Research School for Health Affairs, Bharati Vidyapeeth (Deemed to Be University), Pune, India., Krishnan J; JSS Medical Research, Haryana, India., Yadav A; JSS Medical Research, Haryana, India., Baranwal E; JSS Medical Research, Haryana, India.; Cytel, Pune, India., Singh A; Gennova Biopharmaceuticals Limited, Pune, India., Raghuwanshi A; Gennova Biopharmaceuticals Limited, Pune, India., Agarwal P; Gennova Biopharmaceuticals Limited, Pune, India., Savergave L; Gennova Biopharmaceuticals Limited, Pune, India., Singh S; Gennova Biopharmaceuticals Limited, Pune, India. Sanjay.Singh@gennova.co.in.

مؤلفون مشاركون: GEMCOVAC-OM Study Investigators

المصدر: Nature medicine [Nat Med] 2024 May; Vol. 30 (5), pp. 1363-1372. Date of Electronic Publication: 2024 Apr 18.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , COVID-19 Vaccines*/adverse effects , SARS-CoV-2*/immunology , COVID-19*/prevention & control , COVID-19*/immunology , Immunization, Secondary* , Antibodies, Viral*/immunology , Antibodies, Viral*/blood , Antibodies, Neutralizing*/immunology , Antibodies, Neutralizing*/blood, Humans ; Male ; Female ; Adult ; Middle Aged ; Immunoglobulin G/immunology ; Immunoglobulin G/blood ; Young Adult ; mRNA Vaccines/immunology ; Spike Glycoprotein, Coronavirus/immunology ; Spike Glycoprotein, Coronavirus/genetics ; Immunogenicity, Vaccine/immunology ; ChAdOx1 nCoV-19/immunology

SCR Organism: SARS-CoV-2 variants

المؤلفون: Prosper P; Instituto de Física Aplicada - INFAP, Universidad Nacional de San Luis/CONICET, Argentina, Av. Ejército de los Andes 950, 5700 San Luis, San Luis, Argentina., Rodríguez Puertas R; Universidad del País Vasco (UPV/EHU), Dept. Farmacología, Facultad de Medicina, B° Sarriena S/N, 48940 Leioa, Vizcaya, Spain; Neurodegenerative Diseases, BioCruces Bizkaia Health Research Institute, Barakaldo, Spain., Guérin DMA; Universidad del País Vasco (UPV/EHU) and Instituto Biofisika (CSIC, UPV/EHU), B° Sarriena S/N, 48940 Leioa, Vizcaya, Spain., Branda MM; Instituto de Física Aplicada - INFAP, Universidad Nacional de San Luis/CONICET, Argentina, Av. Ejército de los Andes 950, 5700 San Luis, San Luis, Argentina. Electronic address: mariamartabranda@gmail.com.

المصدر: Vaccine [Vaccine] 2024 Jul 11; Vol. 42 (18), pp. 3916-3929. Date of Electronic Publication: 2024 May 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Vaccines, Virus-Like Particle*/immunology , Epitopes*/immunology , Epitopes*/genetics, Humans ; SARS-CoV-2/immunology ; Molecular Dynamics Simulation ; COVID-19/prevention & control ; COVID-19/immunology ; COVID-19 Vaccines/immunology ; Computational Biology/methods

المؤلفون: Naskar S; ImmunoEngineering and Therapeutics Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, India., Harsukhbhai Chandpa H; ImmunoEngineering and Therapeutics Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, India., Agarwal S; ImmunoEngineering and Therapeutics Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, India., Meena J; ImmunoEngineering and Therapeutics Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, India. Electronic address: jairam.phe@itbhu.ac.in.

المصدر: Vaccine [Vaccine] 2024 Jul 11; Vol. 42 (18), pp. 3857-3873. Date of Electronic Publication: 2024 Apr 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Dengue Vaccines*/immunology , Dengue Virus*/immunology , Serogroup* , Dengue*/prevention & control , Dengue*/immunology , Epitopes, B-Lymphocyte*/immunology, Humans ; Computer Simulation ; Vaccines, Subunit/immunology ; Computational Biology/methods ; Immunodominant Epitopes/immunology ; Antibody-Dependent Enhancement/immunology ; Epitopes/immunology ; Antibodies, Viral/immunology

المؤلفون: Agarwal S; ImmunoEngineering and Therapeutics Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, India., Harsukhbhai Chandpa H; ImmunoEngineering and Therapeutics Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, India., Naskar S; ImmunoEngineering and Therapeutics Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, India., Lal Meena C; Drug Design Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, India., Kumar Panda A; Panacea Biotec Limited, Mohan Cooperative Industrial Estate, Badarpur New Delhi 110044, India., Meena J; ImmunoEngineering and Therapeutics Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, India. Electronic address: jairam.phe@itbhu.ac.in.

المصدر: Vaccine [Vaccine] 2024 Jul 11; Vol. 42 (18), pp. 3899-3915. Date of Electronic Publication: 2024 May 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Scrub Typhus*/immunology , Scrub Typhus*/prevention & control , Orientia tsutsugamushi*/immunology , Epitopes, B-Lymphocyte*/immunology , Epitopes, T-Lymphocyte*/immunology , Vaccines, Subunit*/immunology, Humans ; Molecular Docking Simulation ; Bacterial Vaccines/immunology ; Computer Simulation ; Computational Biology/methods ; T-Lymphocytes, Cytotoxic/immunology ; Machine Learning ; B-Lymphocytes/immunology ; Toll-Like Receptor 2/immunology

المؤلفون: Kirby T

المصدر: The Lancet. Oncology [Lancet Oncol] 2024 Jul; Vol. 25 (7), pp. 837. Date of Electronic Publication: 2024 Jun 06.

نوع المنشور: News; Journal Article

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines*/therapeutic use , Precision Medicine* , Neoplasms*/genetics , Neoplasms*/therapy , State Medicine*, Humans ; United Kingdom ; Clinical Trials as Topic ; mRNA Vaccines